Epigenetic protein could be new therapeutic target in acute myeloid leukemia
The epigenetic protein, EZH2, was found to delay the development…
The epigenetic protein, EZH2, was found to delay the development of acute myeloid leukemia (AML) but also switches sides to maintain tumour growth...